Stay updated on SubQ Lirentelimab Bioavailability in Healthy Adults Clinical Trial
Sign up to get notified when there's something new on the SubQ Lirentelimab Bioavailability in Healthy Adults Clinical Trial page.

Latest updates to the SubQ Lirentelimab Bioavailability in Healthy Adults Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
- Check9 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated to reflect a new version of the study protocol, with significant changes in the study description and criteria for participation. The study now emphasizes a double-blind, randomized, placebo-controlled design for subcutaneous cohorts.SummaryDifference29%
- Check52 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check96 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
Stay in the know with updates to SubQ Lirentelimab Bioavailability in Healthy Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SubQ Lirentelimab Bioavailability in Healthy Adults Clinical Trial page.